At a glance · for buyers and watchdogs
UL Global Pharma has won £52.6m across 3 public-sector buyers, with 6 live contracts.
Why: top buyer NHS England at 100% · 2 active risk flags · 0 modifications.
ESG & policies vault · 0/5
Key governance & sustainability policies. Published documents link out; missing ones are greyed.
Capabilities
What this supplier does, where they sit, who they sell to.
- NHS Framework Agreement, Branded Medicines for London and South of England
- NHS Framework for the North of England, Branded Medicine
Extracted automatically from orifarm.com on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.
Case studies
Delivery stories the supplier has published, with sector and outcome.
No case studies yet
Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.
Buyer references
Named public-sector contacts who have agreed to act as a reference.
No buyer references yet
Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.
Accreditations & memberships
Independently issued. Verification dates cross-checked against issuer registers.
No accreditations recorded
B-Corp, ISO, Cyber Essentials, Living Wage and similar credentials appear here once added by a claimed supplier and cross-checked against the issuing register.
KPI performance
Delivery, budget and satisfaction scores reported quarterly by buyers.
No verified KPI scores yet
Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.
Contracts · 6 live · 5 historic
Pulled from Contracts Finder & Find a Tender. Most recent first.
| Title | Buyer | CPV | Awarded | Value | Term | Status |
|---|---|---|---|---|---|---|
| NHS England | 33600000 | 01 Mar 2023 | £13.7m | 2 yrs | Closed | |
| NHS England | 33600000 | 01 Sept 2022 | £11.7m | 2 yrs | Closed | |
| NHS England | 33600000 | 01 Mar 2022 | £7.7m | 2 yrs | Closed | |
| NHS England | 33600000 | 01 Sept 2021 | £13.3m | 2 yrs | Closed | |
| NHS England | 33600000 | 01 Mar 2021 | £6.2m | 2 yrs | Closed | |
| NHS England | 33600000 | — | — | — | Live | |
| NHS England | 33600000 | — | — | — | Live | |
| Leeds Teaching Hospitals | — | — | — | — | Live | |
| NHS England | 33600000 | — | — | — | Live | |
| The NHS Commissioning Board (operating under the name of NHS England) | 33600000 | — | — | — | Live |
Top buyers · 3 buyers · top 3 = 100%
Share of awarded value. Concentration fires above 40% for any single buyer.
Geography
Distribution of awarded value by buyer region.
Peers
Suppliers with overlapping CPVs & buyers (last 24m). UL Global Pharma highlighted.
| Supplier | SME? | Awarded · 24m | Contracts |
|---|---|---|---|
| Yes | £121.0m | 22 | |
| Yes | £117.6m | 18 | |
| Yes | £95.2m | 12 | |
| Yes | £72.5m | 12 | |
| Yes | £71.2m | 21 | |
UG UL Global Pharma | Yes | — | — |
Red flags · 2 active
Automated scan of Companies House status, charges and insolvency records.
Compliance scorecard
Derived from Companies House filings — not a full supplier-assurance check.
Modifications
Variations to awarded contracts logged under Procurement Act 2023 s.74.
No modifications recorded
No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.
News mentions
UK trade press & nationals, matched to this supplier.
No news mentions found
We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.
Companies House
Live sync — registered details, directors, PSC and SIC codes.
Registered details
- Company no.
- 08482877
- Status
- Dissolved
- Type
- Private limited
- Incorporated
- 10 Apr 2013
- Reg. office
- C/O Bdo Llp 5 Temple Square, Temple Street, Liverpool, L2 5RH
- SIC codes
- 46900
- Last accounts
- 31 Dec 2022
Directors & PSC
- STREET, Anthony Paul — directorAppointed 10 Oct 2022
- STAFFORD, Andrew Paul — directorAppointed 01 Apr 2021
- BRANDHOF, Thomas — directorAppointed 08 Aug 2019
- Christian Ulrik Bogh-Sorensen — person with significant controlownership of shares 25 to 50 percent
- Anne-Charlotte Bogh-Sorensen — person with significant controlownership of shares 25 to 50 percent
- Andreas Henrik Bøgh-Sørensen — person with significant controlownership of shares 25 to 50 percent
- Mr Hans Carl Bogh-Sorensen — person with significant controlvoting rights 50 to 75 percent
Financial
Filed accounts from Companies House.
No financial filings on record
Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.
Org tree
Group structure and ownership.
Independent. No parent company or subsidiaries recorded at Companies House for this entity.
Social value
Commitments mapped to the Government Social Value Model themes.
No social-value commitments yet
Jobs, skills, environmental, inequality and community commitments appear here once a claimed supplier attributes them to awarded contracts, or once we detect them on the supplier’s website.